Effects of prescribed medications on cognition and behavior in frontotemporal lobar degeneration

American Journal of Alzheimer's Disease and other Dementias

Volumn 25, Issue 7, 2010, Pages 566-571

  Irwin, David ^a   Lippa, Carol F ^a   Rosso, Andrea ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

behavior; cognition; frontotemporal dementia; treatment

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; MEMANTINE; NEUROLEPTIC AGENT; PRESCRIPTION DRUG; SEROTONIN UPTAKE INHIBITOR;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; COGNITION; CONFUSION; DIZZINESS; DRUG WITHDRAWAL; FEMALE; FRONTOTEMPORAL DEMENTIA; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MALE; MEDICAL RECORD REVIEW; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; SEDATION; SIDE EFFECT; TREMOR; UNSPECIFIED SIDE EFFECT; VIVID DREAM;

EID: 77957955894     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317510382285     Document Type: Article

References (14)

1. Neary D., Snowden J., Gustafson L., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998 ; 51 (6). 1546-1554.
2. Boxer A., Miller B. Clinical features of frontotemporal dementia. Alz Dis Assoc Disord. 2005 ; 19 (suppl 1). s3 - s6.
3. Massimo L., Grossman M. Patient care and management of frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen. 2008 ; 23 (2). 125-131. (Pubitemid 351550916)
4. Osher JE The mini-mental state examination in behavioral variant frontotemporal dementia and primary progressive aphasia. Am J Alzheimers Dis Other Demen. 2008 ; 22 (6). 468-473.
5. Grinberg A., Lagunoff G., Phillips D., Stern B., Goodman M., Chow T. Multidisciplinary design and implementation of a day program specialized for the frontotemporal dementias. Am J Alzheimers Dis Other Demen. 2008 ; 22 (6). 499-506.
6. Huey E., Putnam K., Grafman J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology. 2006 ; 66 (1). 17-22.
7. Folstein MF, Folstein SE, McHugh PR ĝĝ Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12 (3). 189-198.
8. Rascovsky K., Salmon DP, Lipton AM, et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005 ; 65 (3). 397-403.
9. Mioshi E., Kipps CM, Dawson J., Mitchell A., Graham A., Hodges JR Activities of daily living in frontotemporal dementia and Alzheimer disease. Neurology. 2007 ; 68 (24). 2077-2084.
10. Chow TW, Hynan LS, Lipton AM MMSE scores decline at a greater rate in frontotemporal degeneration than AD. Dement Geriatr Cogn Disord. 2006 ; 22 (3). 194-199.
11. Cummings JL, Mega M., Gray, Rosenberg - Thompson S., Carusi D., Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994 ; 44 (12). 2308-2314.
12. Wicklund AH, Rademaker A., Johnson N., Weitner BB, Weintraub S. Rate of cognitive change measured by neuropsychologic test performance in 3 distinct dementia syndromes. Alzheimer Dis Assoc Disorders. 2007 ; 21 (4). s70 - s78.
13. Litvan I. Therapy and management of frontal lobe dementia patients. Neurology. 2001 ; 56 (suppl 4). S41 - S45.
14. Pasquier F., Richard F., Lebert F. Natural history of frontotemporal dementia: comparison with Alzheimer's disease. Dement Geriatr Cogn Disord. 2004 ; 17 (4). 253-257.